UniProt ID | PEBP1_HUMAN | |
---|---|---|
UniProt AC | P30086 | |
Protein Name | Phosphatidylethanolamine-binding protein 1 | |
Gene Name | PEBP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 187 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Binds ATP, opioids and phosphatidylethanolamine. Has lower affinity for phosphatidylinositol and phosphatidylcholine. Serine protease inhibitor which inhibits thrombin, neuropsin and chymotrypsin but not trypsin, tissue type plasminogen activator and elastase (By similarity). Inhibits the kinase activity of RAF1 by inhibiting its activation and by dissociating the RAF1/MEK complex and acting as a competitive inhibitor of MEK phosphorylation.; HCNP may be involved in the function of the presynaptic cholinergic neurons of the central nervous system. HCNP increases the production of choline acetyltransferase but not acetylcholinesterase. Seems to be mediated by a specific receptor (By similarity).. | |
Protein Sequence | MPVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGKVLTPTQVKNRPTSISWDGLDSGKLYTLVLTDPDAPSRKDPKYREWHHFLVVNMKGNDISSGTVLSDYVGSGPPKGTGLHRYVWLVYEQDRPLKCDEPILSNRSGDHRGKFKVASFRKKYELRAPVAGTCYQAEWDDYVPKLYEQLSGK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MPVDLSKWSGPLS --CCCCHHHCCCCCC | 27.84 | 24275569 | |
7 | Ubiquitination | -MPVDLSKWSGPLSL -CCCCHHHCCCCCCH | 53.31 | - | |
9 | Phosphorylation | PVDLSKWSGPLSLQE CCCHHHCCCCCCHHC | 33.98 | 28857561 | |
13 | Phosphorylation | SKWSGPLSLQEVDEQ HHCCCCCCHHCCCCC | 31.01 | 25159151 | |
28 | Phosphorylation | PQHPLHVTYAGAAVD CCCCCEEEECCCHHH | 9.26 | - | |
39 | Acetylation | AAVDELGKVLTPTQV CHHHHHCCCCCCHHC | 46.85 | 23236377 | |
42 | Phosphorylation | DELGKVLTPTQVKNR HHHCCCCCCHHCCCC | 27.55 | 25159151 | |
44 | Phosphorylation | LGKVLTPTQVKNRPT HCCCCCCHHCCCCCC | 40.53 | 20068231 | |
47 | Ubiquitination | VLTPTQVKNRPTSIS CCCCHHCCCCCCCCE | 37.10 | 21890473 | |
47 | Acetylation | VLTPTQVKNRPTSIS CCCCHHCCCCCCCCE | 37.10 | 25953088 | |
47 | Malonylation | VLTPTQVKNRPTSIS CCCCHHCCCCCCCCE | 37.10 | 26320211 | |
51 | Phosphorylation | TQVKNRPTSISWDGL HHCCCCCCCCEECCC | 35.14 | 22167270 | |
52 | Phosphorylation | QVKNRPTSISWDGLD HCCCCCCCCEECCCC | 19.80 | 22167270 | |
54 | Phosphorylation | KNRPTSISWDGLDSG CCCCCCCEECCCCCC | 20.91 | 22167270 | |
60 | Phosphorylation | ISWDGLDSGKLYTLV CEECCCCCCCEEEEE | 42.76 | 22167270 | |
62 | Acetylation | WDGLDSGKLYTLVLT ECCCCCCCEEEEEEE | 42.12 | 24847203 | |
64 | Phosphorylation | GLDSGKLYTLVLTDP CCCCCCEEEEEEECC | 11.08 | 28152594 | |
64 | Nitration | GLDSGKLYTLVLTDP CCCCCCEEEEEEECC | 11.08 | - | |
65 | Phosphorylation | LDSGKLYTLVLTDPD CCCCCEEEEEEECCC | 22.34 | 24719451 | |
69 | Phosphorylation | KLYTLVLTDPDAPSR CEEEEEEECCCCCCC | 37.70 | - | |
75 | Phosphorylation | LTDPDAPSRKDPKYR EECCCCCCCCCCCCC | 54.40 | 21406692 | |
77 | Acetylation | DPDAPSRKDPKYREW CCCCCCCCCCCCCCC | 80.75 | 23954790 | |
77 | Succinylation | DPDAPSRKDPKYREW CCCCCCCCCCCCCCC | 80.75 | 23954790 | |
80 | Acetylation | APSRKDPKYREWHHF CCCCCCCCCCCCEEE | 68.05 | 70543 | |
81 | Phosphorylation | PSRKDPKYREWHHFL CCCCCCCCCCCEEEE | 21.10 | 27155012 | |
92 | Sulfoxidation | HHFLVVNMKGNDISS EEEEEEECCCCCCCC | 3.87 | 30846556 | |
98 | Phosphorylation | NMKGNDISSGTVLSD ECCCCCCCCCEECCC | 26.11 | 28258704 | |
99 | Phosphorylation | MKGNDISSGTVLSDY CCCCCCCCCEECCCC | 38.53 | 20166139 | |
101 | Phosphorylation | GNDISSGTVLSDYVG CCCCCCCEECCCCCC | 21.88 | 28152594 | |
104 | Phosphorylation | ISSGTVLSDYVGSGP CCCCEECCCCCCCCC | 23.66 | 28152594 | |
106 | Phosphorylation | SGTVLSDYVGSGPPK CCEECCCCCCCCCCC | 11.88 | 28152594 | |
106 | Nitration | SGTVLSDYVGSGPPK CCEECCCCCCCCCCC | 11.88 | - | |
109 | Phosphorylation | VLSDYVGSGPPKGTG ECCCCCCCCCCCCCC | 37.77 | 28152594 | |
113 | Ubiquitination | YVGSGPPKGTGLHRY CCCCCCCCCCCCCEE | 72.70 | 21890473 | |
113 | Acetylation | YVGSGPPKGTGLHRY CCCCCCCCCCCCCEE | 72.70 | 26051181 | |
113 | Malonylation | YVGSGPPKGTGLHRY CCCCCCCCCCCCCEE | 72.70 | 26320211 | |
120 | Phosphorylation | KGTGLHRYVWLVYEQ CCCCCCEEEEEEEEC | 5.80 | 28152594 | |
125 | Phosphorylation | HRYVWLVYEQDRPLK CEEEEEEEECCCCCC | 13.00 | 28152594 | |
129 | Methylation | WLVYEQDRPLKCDEP EEEEECCCCCCCCCC | 37.84 | 115491313 | |
132 | Acetylation | YEQDRPLKCDEPILS EECCCCCCCCCCCCC | 42.18 | 25953088 | |
132 | Ubiquitination | YEQDRPLKCDEPILS EECCCCCCCCCCCCC | 42.18 | 21906983 | |
139 | Phosphorylation | KCDEPILSNRSGDHR CCCCCCCCCCCCCCC | 30.80 | 28258704 | |
150 | Acetylation | GDHRGKFKVASFRKK CCCCCCEEEEEEECE | 40.14 | 27178108 | |
150 | Malonylation | GDHRGKFKVASFRKK CCCCCCEEEEEEECE | 40.14 | 26320211 | |
153 | Phosphorylation | RGKFKVASFRKKYEL CCCEEEEEEECEEEE | 28.68 | 22617229 | |
167 | Phosphorylation | LRAPVAGTCYQAEWD EECCCCCEEEEECHH | 9.78 | 28152594 | |
168 | S-nitrosylation | RAPVAGTCYQAEWDD ECCCCCEEEEECHHH | 2.01 | 19483679 | |
168 | Glutathionylation | RAPVAGTCYQAEWDD ECCCCCEEEEECHHH | 2.01 | 22555962 | |
168 | S-nitrosocysteine | RAPVAGTCYQAEWDD ECCCCCEEEEECHHH | 2.01 | - | |
169 | Phosphorylation | APVAGTCYQAEWDDY CCCCCEEEEECHHHH | 15.59 | 28152594 | |
176 | Phosphorylation | YQAEWDDYVPKLYEQ EEECHHHHHHHHHHH | 19.04 | 28152594 | |
179 | Acetylation | EWDDYVPKLYEQLSG CHHHHHHHHHHHHCC | 54.37 | 23954790 | |
179 | Ubiquitination | EWDDYVPKLYEQLSG CHHHHHHHHHHHHCC | 54.37 | - | |
181 | Phosphorylation | DDYVPKLYEQLSGK- HHHHHHHHHHHCCC- | 14.04 | 25159151 | |
185 | Phosphorylation | PKLYEQLSGK----- HHHHHHHCCC----- | 44.20 | 28985074 | |
187 | Ubiquitination | LYEQLSGK------- HHHHHCCC------- | 54.51 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PEBP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PEBP1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
STC2_HUMAN | STC2 | physical | 16169070 | |
RAF1_HUMAN | RAF1 | physical | 10757792 | |
MP2K1_HUMAN | MAP2K1 | physical | 10757792 | |
MK01_HUMAN | MAPK1 | physical | 10757792 | |
PRDX1_HUMAN | PRDX1 | physical | 22939629 | |
PTGR1_HUMAN | PTGR1 | physical | 22939629 | |
RAF1_HUMAN | RAF1 | physical | 14654844 | |
ARBK1_HUMAN | ADRBK1 | physical | 14654844 | |
ASNS_HUMAN | ASNS | physical | 26344197 | |
CK054_HUMAN | C11orf54 | physical | 26344197 | |
GNPI2_HUMAN | GNPDA2 | physical | 26344197 | |
CH10_HUMAN | HSPE1 | physical | 26344197 | |
LEG3_HUMAN | LGALS3 | physical | 26344197 | |
6PGL_HUMAN | PGLS | physical | 26344197 | |
PPIA_HUMAN | PPIA | physical | 26344197 | |
PRDX5_HUMAN | PRDX5 | physical | 26344197 | |
RIFK_HUMAN | RFK | physical | 26344197 | |
MFTC_HUMAN | SLC25A32 | physical | 26344197 | |
STIP1_HUMAN | STIP1 | physical | 26344197 | |
RAF1_HUMAN | RAF1 | physical | 21831839 | |
LOX15_HUMAN | ALOX15 | physical | 21831839 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-42 AND SER-52, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-42, AND MASSSPECTROMETRY. |